申请人:Agency for Science, Technology and Research
公开号:US20160038567A1
公开(公告)日:2016-02-11
The present invention relates to modified eIF4G1 peptides, uses thereof and pharmaceutical compositions comprising the modified eIF4G1 peptides.
本发明涉及改良的eIF4G1肽,其用途以及包含改良的eIF4G1肽的药物组合物。